The RECOVER Initiative is doing a trial on Paxlovid for long Covid. Here's the listing on ClinicalTrials.gov:
SARS CoV-2 Viral Persistence Study (PASC) - Study of Long COVID-19 (PASC)
Highlights:
Double-blind multi-center trial in the US
1700 participants
They'll take the drug for 15 days...
A thread for general NIH news and discussion
See also: USA: NIH funding for ME/CFS research
Medpage today: "NIH Striving to Avoid False Hope in Chronic Fatigue"
Shame about the title, yet again.
https://www.medpagetoday.com/publichealthpolicy/publichealth/70529
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.